Evaluation of recurrence rate in Canadian patients with stage II/III HR+/HER2-early breast cancer in the real-world setting

被引：0
|
作者：
Marques, Maud
Gambaro, Karen
Basik, Mark
Saad, Fred
Hassan, Saima Noor
Boudreau, Dominique
Vincent, Francois
St-Hilaire, Eve
Mackay, Helen
Abdelsalam, Mahmoud
Guillemette, Stephanie
Leite, Ricardo
Caron, Marc-Andre
Patel, Chandni
Batist, Gerald
机构：
[1] Exactis Innovat, Montreal, PQ, Canada
[2] Segal Canc Ctr, Montreal, PQ, Canada
[3] Univ Montreal, Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[4] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[5] Hop St Sacrement, Quebec City, PQ, Canada
[6] Ctr Integr Univ Sante & Serv Sociaux, Mauricie Ctr Quebec, Trois Rivieres, PQ, Canada
[7] Ctr Oncol Leon Richard, Moncton, NB, Canada
[8] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[9] Moncton City Hosp, Moncton, NB, Canada
[10] Novartis Pharmaceut Canada Inc, Dorval, PQ, Canada
[11] Novartis Canada, Toronto, ON, Canada
[12] Novartis Corp, Montreal, PQ, Canada
[13] Jewish Gen Hosp McGill, Segal Canc Ctr, Montreal, PQ, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23303
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2-early breast cancer
    O'Shaughnessy, Joyce
    Tolaney, Sara M.
    Yardley, Denise A.
    Hart, Lowell
    Razavi, Pedram
    Fasching, Peter A.
    Janni, Wolfgang
    Schwartzberg, Lee
    Kim, Julia
    Akdere, Murat
    McDermott, Courtney
    Khakwani, Aamir
    Pathak, Purnima
    Graff, Stephanie L.
    BREAST, 2025, 81
  • [2] Patient profiles, management and treatment patterns in HR+, HER2-early breast cancer in a real-world setting in Spain
    Martin, Miguel
    Saenz, Jose Angel Garcia
    Blancas, Isabel
    Molero, Alberto
    Atienza, Manuel
    Cervera, Jose Manuel
    Brown, Jacqueline
    Rider, Alex
    Williams, Rhys
    Alba, Emilio
    CANCER RESEARCH, 2022, 82 (04)
  • [3] Real-world treatment of HER2+and HR+/HER2-early breast cancer in county areas of China
    Ji, Y.
    Wang, J.
    Dai, G.
    Zhou, F.
    Meng, Q.
    Wu, Q.
    Qu, H.
    Liu, H.
    Liu, M.
    Tian, Y.
    Tan, X.
    He, W.
    Qin, Z.
    Tang, H.
    Luo, G.
    Liu, Y.
    Ren, Y.
    Luo, J.
    Wang, M.
    Lu, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S1474 - S1474
  • [4] A multinational real-world study on HR+, HER2-early stage breast cancer patients' disease awareness, satisfaction, and involvement in treatment decisions
    Rider, A.
    Method, M.
    Williams, R.
    Piercy, J.
    Clayton, E.
    Brown, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S336 - S336
  • [5] Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2-early breast cancer (EBC) treated with endocrine therapy (ET) in the US.
    Razavi, Pedram
    Ahmed, Mehnaj
    Roush, Ashley
    Parikh, Rohan
    Hitchens, Abigail
    Shen, Sherry
    Safonov, Anton
    Jhaveri, Komal L.
    Robson, Mark E.
    Peacock, Nancy Walker
    Ma, Yanjun
    Santarsiero, Elizabeth Chertow
    Ganapathy, Vaidyanathan
    Shah, Rohan M.
    Amefule, Adaeze Q.
    Lteif, Agnes
    Blakely, L. Johnetta
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN HR+/HER2-EARLY STAGE BREAST CANCER
    Criscitiello, C.
    Wild, R.
    Rider, A.
    Williams, R.
    Mitra, D.
    Bambrick, C.
    Kurosky, S.
    VALUE IN HEALTH, 2020, 23 : S480 - S480
  • [7] Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2-early breast cancer
    Graff, Stephanie L.
    Tolaney, Sara M.
    Hart, Lowell L.
    Razavi, Pedram
    Janni, Wolfgang
    Schwartzberg, Lee S.
    Danyliv, Andriy
    Akdere, Murat
    Ferrusi, Ilia
    Adhikary, Rishi Rajat
    O'Shaughnessy, Joyce A.
    CANCER, 2025, 131 (07)
  • [8] Clinicopathological features of HR+/HER2 low breast cancer in a real-world setting in China
    Min, Z.
    Zhou, F.
    Qu, H.
    Ren, Y.
    Liang, W.
    Liu, M.
    Wang, J.
    Luo, J.
    Tan, X.
    Dai, G.
    Hu, G.
    Meng, Q.
    He, W.
    Wang, H.
    Liu, W.
    Tang, H.
    Wu, Q.
    Liu, H.
    Tian, Y.
    Qin, Z.
    ANNALS OF ONCOLOGY, 2024, 35 : S1412 - S1412
  • [9] A multinational study of real-world treatment patterns among patients with early stage HR+/HER2-breast cancer (BC)
    Criscitiello, C.
    Spurden, D.
    Rider, A.
    Williams, R.
    Corsaro, M.
    Pike, J.
    Law, E. H.
    ANNALS OF ONCOLOGY, 2020, 31 : S42 - S43
  • [10] A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2-early breast cancer in the United States
    Brown, Jacqueline
    Scardo, Savannah
    Method, Michael
    Schlauch, Dan
    Misch, Amanda
    Picard, Shaita
    Hamilton, Erika
    Jones, Suzanne
    Burris, Howard
    Spigel, David
    BMC CANCER, 2022, 22 (01)
12345